Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

By W. Bensinger, P. Martin, B. Storer, R. Clift, S. Forman, R. Negrin, A. Kashyap, M. Flowers, K. Lilleby, T. Chauncey and 5 more. New England Journal of Medicine, 2001

952 citations recorded by the source corpus.

Subfields: Hematology, Oncology

View Paper: https://www.semanticscholar.org/paper/e2eb78166f318a0e10a48c206c13c985c9f60377

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Richard J. Jones
2. A. Emadi
3. R. Brodsky

Citations in the corpus

• Cyclophosphamide and cancer: golden anniversary (2009, background): “Although it does not produce an overall survival advantage, autologous peripheral-blood administration is associated with more rapid engraftment, approximately 5 days sooner compared with BMT”
• Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors (2012, neutral): “First complete remission 21 (8) 30 (11)”